Key facts
- This page summarizes Stanley Stern's Form 4 filing for EKSO BIONICS HOLDINGS, INC. (EKSO).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 06 Dec 2022, 18:04.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Additional SEC filing notes
Footnote F1
The grant of restricted stock units ("RSUs") was approved by the Issuer's Board of Directors on December 4, 2022 in accordance with the terms of the Issuer's Amended and Restated 2014 Equity Incentive Plan. Each RSU represents the economic equivalent of one share of the Issuer's common stock and shall be settled in shares of the Issuer's common stock upon vesting. The RSUs fully vested on December 4, 2022 and were delivered to the Reporting Person upon settlement.
Footnote F2
Includes 51,721 unvested RSUs.